Insights into the molecular roles of heparan sulfate proteoglycans (HSPGs-syndecans) in autocrine and paracrine growth factor signaling in the pathogenesis of Hodgkin's lymphoma (Q38868904)

From Wikidata

Jump to navigation Jump to search

scientific article published on 18 June 2016

Language	Label	Description	Also known as
English	Insights into the molecular roles of heparan sulfate proteoglycans (HSPGs-syndecans) in autocrine and paracrine growth factor signaling in the pathogenesis of Hodgkin's lymphoma	scientific article published on 18 June 2016

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

1 reference

Europe PubMed Central

Insights into the molecular roles of heparan sulfate proteoglycans (HSPGs-syndecans) in autocrine and paracrine growth factor signaling in the pathogenesis of Hodgkin's lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

heparan sulfate proteoglycans

1 reference

based on heuristic

inferred from title

Rajendra Gharbaran

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27317256%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

author name string

Rajendra Gharbaran

1

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

publication date

18 June 2016

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27317256%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

37

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27317256%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27317256%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

11573-11588

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27317256%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Syndecans: new kids on the signaling block

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Functions of cell surface heparan sulfate proteoglycans

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Heparan sulfate proteoglycans as adhesive and anti-invasive molecules. Syndecans and glypican have distinct functions

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

The syndecan-1 ectodomain regulates alphavbeta3 integrin activity in human mammary carcinoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Syndecan-1-mediated cell spreading requires signaling by αvβ3 integrins in human breast carcinoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Syndecan-2 cytoplasmic domain regulates colon cancer cell migration via interaction with syntenin-1.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Syndecan-2 regulates the migratory potential of melanoma cells.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Advances in the molecular functions of syndecan-1 (SDC1/CD138) in the pathogenesis of malignancies

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Cell surface proteoglycan associates with the cytoskeleton at the basolateral cell surface of mouse mammary epithelial cells

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Immunocytochemistry of cell surface heparan sulfate proteoglycan in mouse tissues. A light and electron microscopic study

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

CD138 (syndecan-1), a plasma cell marker immunohistochemical profile in hematopoietic and nonhematopoietic neoplasms

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Histone acetylation and DNA demethylation of B cells result in a Hodgkin-like phenotype.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Evidence of abortive plasma cell differentiation in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Transcription factor IRF4 regulates germinal center cell formation through a B cell-intrinsic mechanism

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Classical Hodgkin's lymphoma shows epigenetic features of abortive plasma cell differentiation

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Functional and molecular characterization of single, (4-hydroxy-3-nitrophenyl)acetyl (NP)-specific, IgG1+ B cells from antibody-secreting and memory B cell pathways in the C57BL/6 immune response to NP.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

A disintegrin and metalloproteinase 17 (ADAM17) mediates inflammation-induced shedding of syndecan-1 and -4 by lung epithelial cells

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Syndecan-1 ectodomain shedding is regulated by the small GTPase Rab5

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Matrix metalloproteinase-9 expression by Hodgkin-Reed-Sternberg cells is associated with reduced overall survival in young adult patients with classical Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Differential surface expression of ADAM10 and ADAM17 on human T lymphocytes and tumor cells

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Heparanase stimulation of protease expression implicates it as a master regulator of the aggressive tumor phenotype in myeloma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Shed syndecan-1 translocates to the nucleus of cells delivering growth factors and inhibiting histone acetylation: a novel mechanism of tumor-host cross-talk

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Nuclear localization of basic fibroblast growth factor is mediated by heparan sulfate proteoglycans through protein kinase C signaling

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Activation of syndecan-1 ectodomain shedding by Staphylococcus aureus alpha-toxin and beta-toxin

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

RANTES (CCL5) induces a CCR5-dependent accelerated shedding of syndecan-1 (CD138) and syndecan-4 from HeLa cells and forms complexes with the shed ectodomains of these proteoglycans as well as with those of CD44.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Sphingosine-1-phosphate receptor 1 in classical Hodgkin lymphoma: assessment of expression and role in cell migration

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Sphingosine-1-phosphate protects endothelial glycocalyx by inhibiting syndecan-1 shedding

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Syndecan-1 (CD138) contributes to prostate cancer progression by stabilizing tumour-initiating cells

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Syndecan-1 expression in locally invasive and metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Circulating sphingosine-1-phosphate and erythrocyte sphingosine kinase-1 activity as novel biomarkers for early prostate cancer detection

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Evaluating sphingosine and its analogues as potential alternatives for aggressive lymphoma treatment

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

An APRIL to remember: novel TNF ligands as therapeutic targets

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Identification of proteoglycans as the APRIL-specific binding partners.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Heparanase Plays a Dual Role in Driving Hepatocyte Growth Factor (HGF) Signaling by Enhancing HGF Expression and Activity

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Mast cells promote the growth of Hodgkin's lymphoma cell tumor by modifying the tumor microenvironment that can be perturbed by bortezomib

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

VEGF-D is expressed in activated lymphoid cells and in tumors of hematopoietic and lymphoid tissues

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Prognostic significance of immunohistochemical expression of the angiogenic molecules vascular endothelial growth factor-A, vascular endothelial growth factor receptor-1 and vascular endothelial growth factor receptor-2 in patients with classical Ho

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Wilms' tumor gene 1: a possible new proangiogenic factor in Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Syndecans in wound healing, inflammation and vascular biology

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

WT1 protein directly regulates expression of vascular endothelial growth factor and is a mediator of tumor response to hypoxia

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

WT1 regulates angiogenesis in Ewing Sarcoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Serum levels of soluble CD30 improve International Prognostic Score in predicting the outcome of advanced Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Different affinities of glycosaminoglycan oligosaccharides for monomeric and dimeric interleukin-8: a model for chemokine regulation at inflammatory sites

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Syndecan-syntenin-ALIX regulates the biogenesis of exosomes

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Proteomic analysis of microvesicles derived from human colorectal cancer cells.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Proteomics analysis of bladder cancer exosomes.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Exosomes in prostate cancer: putting together the pieces of a puzzle

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Frequent expression of follicular dendritic cell markers in Hodgkin lymphoma and anaplastic large cell lymphoma.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

LMP1-induced downregulation of CD99 molecules in Hodgkin and Reed-Sternberg cells

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Epstein-Barr virus latent membrane protein 1 promotes concentration in multivesicular bodies of fibroblast growth factor 2 and its release through exosomes

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Elevated level of plasma basic fibroblast growth factor in multiple myeloma correlates with increased disease activity

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Detection and follow-up of fibroblast growth factor receptor 3 expression on bone marrow and circulating plasma cells by flow cytometry in patients with t(4;14) multiple myeloma.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Serum syndecan-1, basic fibroblast growth factor and osteoprotegerin in myeloma patients at diagnosis and during the course of the disease

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

FGF2 binding, signaling, and angiogenesis are modulated by heparanase in metastatic melanoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Protein tyrosine kinases in malignant melanoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

A pivotal role for ERK in the oncogenic behaviour of malignant melanoma?

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Heparanase enhances the insulin receptor signaling pathway to activate extracellular signal-regulated kinase in multiple myeloma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Comprehensive analysis of homeobox genes in Hodgkin lymphoma cell lines identifies dysregulated expression of HOXB9 mediated via ERK5 signaling and BMI1.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Expression of B-cell markers in classical hodgkin lymphoma: a tissue microarray analysis of 330 cases

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

The expression of fibroblast growth factors and their receptors in Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Overexpression of HOXB9 promotes metastasis and indicates poor prognosis in colon cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Syndecan-1 promotes the angiogenic phenotype of multiple myeloma endothelial cells.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Vascular endothelial-cadherin stimulates syndecan-1-coupled insulin-like growth factor-1 receptor and cross-talk between αVβ3 integrin and vascular endothelial growth factor receptor 2 at the onset of endothelial cell dissemination during angiogenes

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Insulin-like growth factor 1 receptor is a prognostic factor in classical Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Therapeutic renaissance of thalidomide in the treatment of haematological malignancies

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

A phase II study of thalidomide and vinblastine for palliative patients with Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Lenalidomide in patients with refractory or multiple relapsed Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Effects of the anti-VEGF monoclonal antibody bevacizumab in a preclinical model and in patients with refractory and multiple relapsed Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

The hepatocyte growth factor/Met pathway controls proliferation and apoptosis in multiple myeloma.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Heparanase regulates levels of syndecan-1 in the nucleus

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Functional analysis of HGF/MET signaling and aberrant HGF-activator expression in diffuse large B-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Expression of hepatocyte growth factor and its receptor c-met in human leukemia-lymphoma cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Expression of the c-met proto-oncogene and its ligand, hepatocyte growth factor, in Hodgkin disease

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Expression of the c-Met oncogene by tumor cells predicts a favorable outcome in classical Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

PI3Kδ inhibitor, GS-1101 (CAL-101), attenuates pathway signaling, induces apoptosis, and overcomes signals from the microenvironment in cellular models of Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Molecular Pathogenesis of Hodgkin's Lymphoma: Increasing Evidence of the Importance of the Microenvironment

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Syndecan-1 enhances proliferation, migration and metastasis of HT-1080 cells in cooperation with syndecan-2.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Syndecan-1 couples the insulin-like growth factor-1 receptor to inside-out integrin activation

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Cell growth and matrix invasion of EBV-immortalized human B lymphocytes is regulated by expression of alpha(v) integrins

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Cytokine regulation of syndecan-1 and -2 gene expression in human periodontal fibroblasts and osteoblasts

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Imatinib as a key inhibitor of the platelet-derived growth factor receptor mediated expression of cell surface heparan sulfate proteoglycans and functional properties of breast cancer cells.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Micro-vessel density and the expression of vascular endothelial growth factor (VEGF) and platelet-derived endothelial cell growth factor (PdEGF) in classical Hodgkin lymphoma (HL).

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Histological expression of angiogenic factors: VEGF, PDGFRalpha, and HIF-1alpha in Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Autocrine- and paracrine-activated receptor tyrosine kinases in classic Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Syndecan-1 up-regulated by ephrinB2/EphB4 plays dual roles in inflammatory angiogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Induction of endoplasmic reticulum stress by sorafenib and activation of NF-κB by lestaurtinib as a novel resistance mechanism in Hodgkin lymphoma cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Characterization of heparin and heparan sulfate domains binding to the long splice variant of platelet-derived growth factor A chain

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Syndecan-4 regulates platelet-derived growth factor-mediated MAP kinase activation by altering intracellular reactive oxygen species

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Transmembrane domain-induced oligomerization is crucial for the functions of syndecan-2 and syndecan-4

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Hodgkin-Reed-Sternberg cells in classical Hodgkin lymphoma show alterations of genes encoding the NADPH oxidase complex and impaired reactive oxygen species synthesis capacity

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

The interaction of the transforming growth factor-betas with heparin/heparan sulfate is isoform-specific.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Transforming growth factor-beta 1 is a heparin-binding protein: identification of putative heparin-binding regions and isolation of heparins with varying affinity for TGF-beta 1.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Soluble and membrane-bound TGF-β-mediated regulation of intratumoral T cell differentiation and function in B-cell non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Transforming growth factor beta 1 messenger RNA in Reed-Sternberg cells in nodular sclerosing Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Abundant expression of transforming growth factor-β1 and -β2 by Hodgkin's reed-sternberg cells and by reactive T lymphocytes in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

The role of cytotoxic and regulatory T cells in relapsed/refractory Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

The role of cytokines in classical Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

The role of syndecan-1 in cellular signaling and its effects on heparan sulfate biosynthesis in mesenchymal tumors

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Syndecan-1 expression in epithelial cells is induced by transforming growth factor beta through a PKA-dependent pathway

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

TGF-beta signaling and the fibrotic response

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

TGF-beta and fibrosis in different organs - molecular pathway imprints

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Oxidative stress alters syndecan-1 distribution in lungs with pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Interleukin-6 regulates expression of the syndecan-1 proteoglycan on B lymphoid cells

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Novel genes and pathways modulated by syndecan-1: implications for the proliferation and cell-cycle regulation of malignant mesothelioma cells

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Syndecan-1 modulates β-integrin-dependent and interleukin-6-dependent functions in breast cancer cell adhesion, migration, and resistance to irradiation

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Autocrine interleukin-6 production and highly malignant multiple myeloma: relation with resistance to drug-induced apoptosis

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Hodgkin and Reed-Sternberg cells express interleukin 6 and interleukin 6 receptors

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Plasma Cytokine and Soluble Receptor Signature Predicts Outcome of Patients With Classical Hodgkin's Lymphoma: A Study From the Groupe d'Etude des Lymphomes de l'Adulte

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Fibrosis Marker Syndecan-1 and Outcome in Patients With Heart Failure With Reduced and Preserved Ejection Fraction

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Prognostic Significance of T-Cell or Cytotoxic Molecules Phenotype in Classical Hodgkin’s Lymphoma: A Clinicopathologic Study

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5118-7

21 January 2018

Epstein-barr virus latent membrane protein 1 induces and causes release of fibroblast growth factor-2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Eosinophils are the major source of transforming growth factor-beta 1 in nodular sclerosing Hodgkin's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-7, interleukin-8, soluble TNF receptor, and p53 protein levels are elevated in the serum of patients with Hodgkin's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. The Nordic Myeloma Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study to evaluate lenalidomide in combination with metronomic-dose cyclophosphamide in patients with heavily pretreated classical Hodgkin lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix-metalloproteinases in Hodgkin lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of CD44 splice variant v10 in Hodgkin's disease is associated with aggressive behaviour and high risk of relapse

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum levels of soluble syndecan-1 in Hodgkin's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Syndecan-1 and angiogenic cytokines in multiple myeloma: correlation with bone marrow angiogenesis and survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 6 expression by Hodgkin/Reed-Sternberg cells is associated with the presence of 'B' symptoms and failure to achieve complete remission in patients with advanced Hodgkin's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum syndecan-1: a new independent prognostic marker in multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemistry accurately predicts FGFR3 aberrant expression and t(4;14) in multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiogenic molecules in Hodgkin's disease: results from sequential serum analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

3D Telomere FISH defines LMP1-expressing Reed–Sternberg cells as end-stage cells with telomere-poor ‘ghost’ nuclei and very short telomeres

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mapping of matrix metalloproteinase cleavage sites on syndecan-1 and syndecan-4 ectodomains

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

B lymphocytes express and lose syndecan at specific stages of differentiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocyte growth factor in myeloma patients treated with high-dose chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HOXB9 expression promoting tumor cell proliferation and angiogenesis is associated with clinical outcomes in breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of platelet-derived growth factor-AB in tumour growth and angiogenesis in relation with other angiogenic cytokines in multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of epithelial syndecan-1 expression by inflammatory cytokines

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiogenesis in Hodgkin's lymphoma: a morphometric approach in 286 patients with prognostic implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical evidence of a role for transforming growth factor beta in the pathogenesis of nodular sclerosing Hodgkin's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression status of BCL-6 and syndecan-1 identifies distinct histogenetic subtypes of Hodgkin's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protection of transforming growth factor-beta 1 activity by heparin and fucoidan

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reed-Sternberg cells of classical Hodgkin's disease react with the plasma cell-specific monoclonal antibody B-B4 and express human syndecan-1

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High levels of soluble syndecan-1 in myeloma-derived bone marrow: modulation of hepatocyte growth factor activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Syndecan-4 is expressed by B lineage lymphocytes and can transmit a signal for formation of dendritic processes

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differentiation of mesothelioma cells is influenced by the expression of proteoglycans

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

B-cell differentiation immunophenotypes in classical Hodgkin lymphomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasminogen activator inhibitor-1 supports IL-8-mediated neutrophil transendothelial migration by inhibition of the constitutive shedding of endothelial IL-8/heparan sulfate/syndecan-1 complexes

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transforming growth factor-beta 1-induced collagen production in cultures of cardiac fibroblasts is the result of the appearance of myofibroblasts

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocyte growth factor/scatter factor promotes adhesion of lymphoma cells to extracellular matrix molecules via alpha 4 beta 1 and alpha 5 beta 1 integrins

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequent expression of interleukin-10 by Epstein-Barr virus-harboring tumor cells of Hodgkin's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Mi15 monoclonal antibody (anti-syndecan-1) is a reliable marker for quantifying plasma cells in paraffin-embedded bone marrow biopsy specimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of BCL-6, CD10, CD138 and MUM-1 expression in diffuse large B-cell lymphoma patients: CD138 is a marker of poor prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Syndecan-1 (CD138) expression in human non-Hodgkin lymphomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma heparanase as a significant marker of treatment response in children with Hodgkin lymphoma: pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparanase promotes the spontaneous metastasis of myeloma cells to bone

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The plateled-derived growth factor level (PDGF) in Hodgkin's disease and non-Hodgkin's lymphoma and its relationship disease activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Reed-Steinberg cell: molecular characterization by proteomic analysis with therapeutic implications.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum CD44 in malignant lymphoma: an association with treatment response

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Plasma levels of VEGF-C, VEGF-D, VEGFR-2 and VEGFR-3 in patients with newly diagnosed lymphomas]

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum cytokine in response to chemo-radiotherapy for Hodgkin's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD138/syndecan-1: a useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies

1 reference

https://pubmed.ncbi.nlm.nih.gov/27317256

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38868904&oldid=2202206278"